Boston, MA USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Dr. Gordon Weir, Co-Head of Section on Islet Cell and Regenerative Biology at Joslin, to Receive the Albert Renold Award for his Significant Impact as a Mentor from the American Diabetes Association


– Gordon Weir, M.D., Diabetes Research and Wellness Foundation Chair, Co-Head of Section on Islet Cell and Regenerative Biology at Joslin Diabetes Center and Professor of Medicine at Harvard Medical School, has been selected as the recipient of...
26-Apr-2016 4:05 PM EDT Add to Favorites

Solving a Genetic Mystery in Type 1 Diabetes


In type 1 diabetes, the immune system attacks the body’s own insulin-producing cells. Scientists understand reasonably well how this autoimmune attack progresses, but they don’t understand what triggers the attack or how to stop it, says Stephan...
11-Apr-2016 11:05 AM EDT Add to Favorites

Natural Killer Cells Help to Drive Inflammation and Insulin Resistance


In obesity, the body’s immune system can treat tissues as if they are suffering from a low-grade chronic infection. This obesity-induced inflammation is an important contributor to insulin resistance, a condition that can progress into type 2...
31-Mar-2016 3:05 PM EDT Add to Favorites

New Scanning Technology Benefits Diabetic Eye Care in National Telemedicine Trial


In a national clinical trial led by Joslin Diabetes Center’s Beetham Eye Institute, ultrawide field (UWF) scanning technology significantly improved the ability of experts at a remote central location to identify diabetic retinopathy in a patient,...
8-Mar-2016 11:05 AM EST Add to Favorites

Dr. Rohit N. Kulkarni, Senior Investigator at Joslin Diabetes Center, Named Professor of Medicine at Harvard Medical School


Rohit N. Kulkarni, M.D., Ph.D., Senior Investigator in the Section on Islet Cell and Regenerative Biology at Joslin Diabetes Center, has been named Professor of Medicine by Harvard Medical School.
23-Feb-2016 10:05 AM EST Add to Favorites

JDRF Appoints Lori Laffel, M.D., M.P.H., Chief of Pediatrics at Joslin Diabetes Center, to Research Advisory Committee


Lori Laffel, M.D., M.P.H., has been appointed to the newly formed Research Advisory Committee (RAC) of the JDRF, the leading global organization funding type 1 diabetes (T1D) research.
16-Feb-2016 10:05 AM EST Add to Favorites

American Diabetes Association Presents Guidance on Managing Diabetes in Older Adults in Long-Term Care Facilities


To ensure that this population receives proper care, the American Diabetes Association has issued its first position statement to address the management of diabetes in long-term care facilities, which include assisted living, skilled nursing and...
2-Feb-2016 11:05 AM EST Add to Favorites

Brown University Medical School Philanthropy Leader John A. Perry Joins Joslin Diabetes Center as Chief Development Officer


Joslin Diabetes Center, the, the world-renowned diabetes expert, has appointed John A. Perry, CFRE, a skilled fundraising professional with extensive experience in healthcare philanthropy, as Chief Development Officer effective February 1.
2-Feb-2016 11:05 AM EST Add to Favorites

Our Experts on Newswise

Dr. Lori Laffel, Chief of Pediatrics at Joslin Diabetes Center, Available to Comment on Type 1 Diabetes and Life Expectancy Studies


6-Jan-2015 11:00 AM EST

Back to School with Dr. Lori Laffel from Joslin Diabetes Center


Lori Laffel, M.D., MPH, Chief of the Pediatric, Adolescent and Young Adult Section at Joslin Diabetes Center and Associate Professor of Pediatrics at Harvard Medical School, oversees the largest pediatric diabetes clinic in New England has over 25...
15-Aug-2014 8:00 AM EDT

Joslin Diabetes Center’s Cathy Carver Deciphers the ACA for People with Diabetes


13-Nov-2013 1:00 PM EST

Expert Available: Bariatric Surgery for Diabetes

The International Diabetes Federation now recommends that surgery be considered as a treatment for obese patients with type 2 diabetes. Dr. Allison Goldfine, head of clinical research at Joslin Diabetes Center, is available for comment.
29-Mar-2011 9:00 AM EDT

Q&A: Howard Wolpert, M.D., and the Quest for an Artificial Pancreas


Emerging technologies such as continuous glucose monitoring (CGM) are helping people with type 1 diabetes manage their condition—what are the next steps? Howard Wolpert, M.D., of Joslin Diabetes Center discusses his current research and the global...
1-Oct-2010 1:00 PM EDT

Our YouTube Videos